Angiotensin II blockade followed by growth hormone as adjunctive therapy after experimental myocardial infarction
- 1 September 1998
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 4 (3) , 213-224
- https://doi.org/10.1016/s1071-9164(98)80008-0
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The role of hypertrophy and growth factors inheart failureJournal of Cardiac Failure, 1996
- Cardiovascular Effects of Insulin-Like Growth Factor-1 and Growth Hormone in Chronic Left Ventricular Failure in the RatCirculation, 1996
- A Preliminary Study of Growth Hormone in the Treatment of Dilated CardiomyopathyNew England Journal of Medicine, 1996
- Survival after myocardial infarction in rats: captopril versus losartanJournal of the American College of Cardiology, 1996
- Beneficial Effects of Growth Hormone and Insulin-Like Growth Factor-1 in Experimental Heart Failure in Rats Treated with Chronic ACE InhibitionJournal of Cardiovascular Pharmacology, 1995
- Growth Hormone Improves Cardiac Performance in Experimental Heart FailureCirculation, 1995
- Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.Journal of Clinical Investigation, 1995
- Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.Circulation, 1994
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Influence of chronic captopril therapy on the infarcted left ventricle of the rat.Circulation Research, 1985